Session Information
-
WCLC 2021
2022 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
FP02 - Health Services Research/Health Economics
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters (Featured)
- Track: Health Services Research/Health Economics
-
+
FP02.01 - Utilization and Refusal of Adjuvant Chemotherapy for Non-Small Cell Lung Cancer: A National Cancer Database Study
00:00 - 00:00 | Presenter: Ranjan Pathak
- Abstract
Loading...
-
+
P53 - Novel Therapeutics and Targeted Therapies - Others
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
-
+
P53.06 - A Multi-Phase Quality Initiative to Improve Processes of Care for Non-small Cell Lung Cancer (NSCLC) in US Community Cancer Centers
00:00 - 00:00 | Presenter: Matthew Smeltzer
- Abstract
Loading...
-
+
MA12 - The Impact of COVID-19 on How We Treat Thoracic Cancer Now and in the Future
- 20:00 - 21:00
- 9/12/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Management of Lung Cancer in the Era of COVID-19
-
+
MA12.01 - A Novel Program Offering Remote, Asynchronous Subspecialist Input in Thoracic Oncology: Early Experience During a Pandemic
20:00 - 20:05 | Presenter: Howard West
- Abstract
Loading...
-
+
ES13 - Ethics, Costs, and Regulation of Lung Cancer*
- 17:30 - 18:05
- 9/14/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Education Session
- Track: Health Services Research/Health Economics
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:Bishal Gyawali, Loretta Erhunmwunsee
-
+
ES13.04 - What Evidence Level is Enough for Approval and Reimbursement of Novel Cancer Drugs? Lessons from Lung Cancer
17:36 - 17:38 | Presenter: Howard West
- Abstract
Loading...
